Sherry-Ann Brown, MD, PhD, FACC, FAHA Profile picture
💃🏽#AmericasExpertCardiologist #CardioOnc #CardioOncology #cvPrev #Innovation. @MyHeartRisk @PrevCardioOncus. @MayoClinicCV Trained. Tweets=mine RT/Fol≠endorse
Apr 7, 2020 13 tweets 11 min read
1/ Hot-off-the-press 🔥✍🏽🗣

Precision #CardioOncology: Systems-based Perspective on Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors

#PrecisionCardioOnc @SpringerNature

Latest manuscript w/ @MayoClinicCV @mayocvonc & edited by @AnaBaracCardio

rdcu.be/b3q0Y 2/ 🔥✍🏽🗣

A broad spectrum of #CVD toxicities can be seen with targeted therapies or #ICIs

Toxicities of one or the other can include cardiomyopathy, HF, myocarditis, venous or arterial thrombosis, progression of atherosclerosis, QTc prolongation, or arrhythmias

#CardioOnc
Jan 21, 2020 12 tweets 7 min read
1/ Hot-off-the-press!

Tweetorial on Role of Angiotensin‐Converting Enzyme Inhibitors & β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Pts

ahajournals.org/doi/10.1161/JA…

#CardioOnc #CardioOncology #PrevCardioOnc

@avolgman @AnaBaracCardio @DrTochiCardiOnc 2/ Approx 4 million American 👩🏽👩‍🦳 are currently living with a hx of invasive breast ca, w/ 270,000 diagnosed within the past year. Among these 👩🏽👩‍🦳, 64% are aged ≥65 years. Among older 👩🏽👩‍🦳 survivors of breast cancer, cardiovascular disease (#CVD) is the leading cause of death
Jan 10, 2020 12 tweets 16 min read
1/ Preventive Cardio-Oncology Tutorial #PrevCardioOnc @PrevCardioOnc #CardioOnc #CardioOncology

“The time has come for cardiovascular disease (CVD) prevention to play a more prominent role in cardio-oncology.”

tinyurl.com/PrevCardioOncT… 2/ “A myriad of novel cardiotoxic chemotherapeutic & immunotherapeutic drugs are continuously being developed in #Oncology, with diverse cardiovascular (CV) effects.”

tinyurl.com/PrevCardioOncT…

#PrevCardioOnc @PrevCardioOnc #CardioOnc #CardioOncology